| Date | Title | Description |
| 10.10.2024 | Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes, Upcoming Webinar Hosted by Xtalks | www.medpace.com
In this free webinar, gain insights into the critical aspects and challenges of psychiatry clinical trials. Attendees will learn best practices for successfully conducting psychiatry trials. The featured speakers will discus... |
| 24.09.2024 | Innovative Approaches in Metabolic Dysfunction-Associated Steatohepatitis Clinical Research, Upcoming Webinar Hosted by Xtalks | www.medpace.com
In this free webinar, learn about operational efficiency in metabolic dysfunction-associated steatohepatitis studies by ensuring seamless integration of data from sample collection to analysis. Attendees will gain insights i... |
| 15.08.2024 | Skanska builds new office building in Cincinnati, Ohio, USA, for USD 164M, about SEK 1.7 billion | Skanska builds new office building in Cincinnati, Ohio, USA, for USD 164M, about SEK 1.7 billion
Thu, Aug 15, 2024 07:30 CET Report this content
Skanska has signed a contract with Medpace, a clinical research company, for the construction o... |
| 01.08.2024 | Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach, Upcoming Webinar Hosted by Xtalks | www.medpace.com
In this free webinar, learn about the complex factors contributing to obesity and strategies for enhancing patient retention in obesity trials. The featured speakers will discuss considerations for endpoint protection throug... |
| 13.05.2024 | Women's Health Awareness Month: The Evolving Women's Health Clinical Development Landscape, Upcoming Webinar Hosted by Xtalks | www.medpace.com
In this free webinar, gain insights into Women's Health clinical development, including the underrepresentation and underfunding of Women's Health research, and how the landscape has evolved over time. The featured speakers ... |
| 12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030
The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
| 03.08.2023 | Optimizing Study Execution in Obesity Clinical Trials: Considerations for Recruitment and Retention, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars The session will be invaluable for professionals working within Clinical Affairs, Clinical Research, Clinical Pharmacology, Clinical Outsourcing, Clinical Operations, Regulatory Affairs and Medical Affairs.
TORO... |
| 07.06.2023 | Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials, Upcoming Webinar Hosted by Xtalks | An understanding of integrated approaches toward expanding this population in clinical trials will ultimately benefit not only both patients and Sponsors alike, but also will have a positive global impact on disease burden while also contin... |
| 13.02.2023 | Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals, Upcoming Webinar Hosted by Xtalks | A hub and spoke model for treating and referral sites allows efficient recruitment planning and wide patient study access, however, challenges the study execution with long-distance or cross-border patient management.
TORONTO (PRWEB) Februa... |
| 31.10.2022 | Radiation Toxicity — Considerations for Implementing Radiation Dose Limits in Radiopharmaceutical Trials, Upcoming Webinar Hosted by Xtalks | For clinical radiopharmaceutical studies, the broader team must understand the background of radiation dosimetry, radiation toxicity, normal organ dose constraints and how to capture these metrics within clinical trial data management.
TORO... |
| 29.09.2022 | Achieving Successful Cell Therapy Outcomes through Integrated Expertise, Upcoming Webinar Hosted by Xtalks | Successful preclinical to clinical transition requires careful planning with the aim of avoiding mistakes and surmounting barriers common to the development and operation of cell therapy trials.
TORONTO (PRWEB) September 29, 2022
As the cel... |
| 18.08.2022 | Liquid Biopsy in Oncology: Opportunities and Challenges, Upcoming Webinar Hosted by Xtalks | Although liquid biopsy is expected to complement and not replace tissue biopsy in the foreseeable future, its non-invasive nature promises to open new eras in clinical oncology.
TORONTO (PRWEB) August 18, 2022
A liquid biopsy is a simple an... |
| 14.06.2022 | Considerations for Neuroscience Trials with Direct Administration to the CNS, Upcoming Webinar Hosted by Xtalks | The modern-day application of intraparenchymal, intracerebroventricular and intrathecal delivery in neuroscience trials comes with many clinical, operational and regulatory challenges.
TORONTO (PRWEB) June 14, 2022
In this free webinar, lea... |
| 12.05.2022 | Considerations for Patient Diversity in Cardiovascular Clinical Trials, Upcoming Webinar Hosted by Xtalks | The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.
TORONTO (PRWEB) May 1... |
| 07.02.2022 | The Complexities of Pediatric Rare Disease Clinical Trials: Regulatory and Operational Strategies for Success, Upcoming Webinar Hosted by Xtalks | Identifying potential challenges before they arise while mitigating associated risks ensures studies are best positioned for success.
TORONTO (PRWEB) February 07, 2022
Strategic planning and execution are crucial when implementing rare dise... |
| 24.11.2021 | Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays, Upcoming Webinar Hosted by Xtalks | Reagent specificity is important as the assay relies on the ability to distinguish free vs. bound and total receptor.
TORONTO (PRWEB) November 24, 2021
In clinical trials and drug development, receptor occupancy assays by flow cytometry are... |
| 28.10.2021 | Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials, Upcoming Webinar Hosted by Xtalks | Join us as these experts share critical considerations and lessons learned in the integration and application of wearable devices into decentralized clinical trials (DCTs).
TORONTO (PRWEB) October 28, 2021
In this webinar, Medpace, a global... |
| 02.08.2021 | [Webinar] Getting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry | The demands for radiopharmaceutical dosimetry are growing rapidly. This need impacts design of clinical trials for a wide variety of oncologic diseases (e.g. neuroendocrine tumors (NETs), prostate cancer, lung, breast, and GI cancer) and is... |
| 19.07.2021 | Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Discussion with Dr. James Januzzi, MD, Upcoming Webinar Hosted by Xtalks | Determination of appropriate study endpoints is the backbone of any drug development program. Cardiovascular clinical research requires a precise approach to ensuring that study targets are met.
TORONTO (PRWEB) July 19, 2021
In cardiovascul... |
| 11.05.2021 | Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID Pandemic, Upcoming Webinar Hosted by Xtalks | In this webinar, we bring together AMR experts to discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for antibacterial drugs.
TORONTO (PRWEB) May 11, 2021
The World Health Organization (WHO... |
| 21.04.2021 | MEDPACE HOLDINGS, INC.
Webinar: Revisiting and Rebuilding Clinical Development for Antimicrobial Resistant Drugs – Lessons Learned During the COVID Pandemic | The World Health Organization (WHO) has identified antimicrobial resistance (AMR) as one of the biggest threats to global health. Despite the concerns raised by many in the public health community, the antibiotic pipeline is still quite lim... |
| 25.03.2021 | Medpace : Chronic Kidney Disease & Its Impact on Clinical Development – Part 2 | This post is the second of a three-part blog series. Click here to read Part 1.
Cardiovascular Disease & Chronic Kidney Disease
According to the World Health Organization (WHO), cardiovascular disease (CVD) is responsible for 31 percent... |
| 10.03.2021 | Medpace Holdings, Inc. to Report First Quarter 2021 Financial Results on April 26, 2021 | CINCINNATI--(BUSINESS WIRE)--Mar 10, 2021--
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2021 financial results after the market close on Monday, April 26, 2021. The Company will ho... |
| 10.02.2021 | Centered on Sites: Committing to a Collaborative Approach for Rare Disease Clinical Trial Success, Upcoming Webinar Hosted by Xtalks | COVID-19 has further amplified the need to work collaboratively as we continue to drive rare disease clinical research forward.
TORONTO, Ontario (PRWEB) February 10, 2021
Investigative sites are fundamental to the success of clinical trials... |
| 12.08.2016 | Medpace Holdings Announces Pricing of Initial Public Offering | Medpace Holdings, Inc., a Cincinnati, Ohio-based clinical contract research organization (CRO), announced the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price of $23.00 per share.
In addi... |
| 28.06.2016 | This is what stands out in $150M IPO filing for CRO Medpace | Medpace has 2,200 employees spanning 35 countries, though the United States accounts for 98 percent of its net service revenue, according to the filing. The CRO’s areas of therapeutic focus include oncology, cardiology, metabolic disease, e... |
| 14.06.2011 | Mid-sized CROs perform as good or better than larger ones, survey says | Kevin Olson, CEO of ISR, said that the survey responses and data do not show why mid-sized CROs as a whole scored better than larger ones. But he theorizes the smaller CROs might be seen as offering better service because while they may not... |
| 26.02.2010 | Cincinnati's Akebia starts Phase 1b clinical trial for anemia drug | During the Phase 1b trial, three doses of AKB-6548 will be administered to about 33 healthy volunteers at Cincinnati contract research organization Medpace Inc. over a 10-day period to evaluate the drug’s safety, tolerability and movement t... |
| 12.02.2010 | Night Read (Ohio): Pediatricians help lead earthquake disaster response in Haiti | HealthBridge, the Cincinnati-based regional health information exchange that connects hospitals and doctors offices, will receive a $9.7 million grant from the federal stimulus bill, according to the Cincinnati Enquirer.
University Hospital... |
| 11.12.2009 | Forum Health reportedly gets interest from four bidders, should it decide to sell — MedCity Evening Read, Dec. 11, 2009 | Within3, the provider of online communities for health professionals in Cleveland, announced the release of mobile applications for both the Blackberry and iPhone. A surge of customer requests fueled the need for a handheld solution that i... |
| - | Mid-sized CROs perform as good or better than larger ones, survey says | Pharmaceutical companies evaluating which clinical research organizations to work with might want to take note that perhaps size doesn’t matter.
As a group, mid-sized CROs performed quite well or even better than their larger counterparts a... |
| - | Cincinnati's Akebia starts Phase 1b clinical trial for anemia drug | CINCINNATI, Ohio — Small molecule discovery and development company Akebia Therapeutics Inc. has started a second Phase 1 clinical trial of its anemia drug–another baton hand-off in a race with big drug companies to get to market first with... |
| - | This is what stands out in $150M IPO filing for CRO Medpace | Medpace is moving forward with an initial public stock offering, a filing that comes two years after a private equity firm acquired the contract research organization. Cincinnati-based Medpace aims to raise as much as $150 million, accordin... |
| - | Forum Health reportedly gets interest from four bidders, should it decide to sell — MedCity Evening Read, Dec. 11, 2009 | News and notes from the day in MedCity, Ohio:
Ohio Gov. Ted Strickland called financially troubled Forum Health in Youngstown “a critically urgent situation,” while three federal legislators appealed to President Obama for financial assi... |
| - | Night Read (Ohio): Pediatricians help lead earthquake disaster response in Haiti | News and notes from the day in MedCity, Ohio:
Case Western Reserve University faculty from the Center for Global Child Health and pediatricians at University Hospitals Rainbow Babies & Children’s Hospital are helping to lead the pediatr... |
